Need a mesothelioma lawyer? We will fight for you!
› $4.85 Billion settlement in drug case
January 11th, 2010 by Kurt Niland
WhyQuit, an organization that advocates quitting smoking using the cold turkey method, recently published an article that takes Pfizer to task over its latest Chantix ads. The group claims that the pharmaceutical company’s new television commercials hide information from the viewer – information that, if known, would likely dissuade most smokers from using the drug as a smoking cessation aid.
November 9th, 2009 by Kurt Niland
Reynolds American, the second largest American producer of cigarettes and other tobacco products, is in the advanced stages of negotiating a purchase of Niconovum, a Swedish company that manufactures smoking cessation products. If the deal works, as it appears it will, it shows the determination of the tobacco giants to cash in on the “whole cycle of a smoker from the first puff to the last piece of gum,” said Chip Brian, a business analyst for SmarTrend.
October 29th, 2009 by Kurt Niland
It’s difficult for some coffee drinkers to imagine life before decaf. Pretty soon it may be difficult for some smokers to imagine life before de-nic. A New York company called 22nd Century Limited recently announced that it is making progress in its development of a very low nicotine (VLN) cigarette that uses a specially engineered and proprietary form of tobacco.
September 14th, 2009 by Kurt Niland
Chantix made an appearance in last week’s issue of the Journal of the American Medical Association (JAMA) when one contributor wrote that the Food and Drug Administration has acknowledged receiving nearly 100 reports of suicide and nearly 200 reports of attempted suicide likely linked to the use of Chantix. Additionally, the FDA also said it is compliling reports of Chantix patients being involved in traffic accidents.
September 8th, 2009 by Kurt Niland
The family of musician Carter Albrecht has filed a lawsuit in a Dallas federal court against Chantix manufacturer Pfizer Inc. Ken and Judy Albrecht allege that the drug manufacturer is responsible for the musician’s death in 2007 because it marketed Chantix, which Carter had been taking at the time of his death, while knowing it to be unsafe.
August 27th, 2009 by Kurt Niland
The Food and Drug Administration has approved the new labeling for Chantix packaging. In July, we reported that the agency said it would require stronger warnings on all Chantix labeling, as well as packaging for other smoking cessation drugs Wellbutrin and Zyban (bupropion hydrochloride). All of the drugs have been linked to serious behavioral changes and other symptoms.
July 28th, 2009 by Kurt Niland
I have that “born late” feeling. I quit smoking before I had a chance to “smoke” electronic cigarettes, the latest and most overtly sci-fi smoking cessation tool to come along in my lifetime. My first attempt to quit smoking was in 1989, 4 years after I started smoking, when my college roommate yanked a brand-new pack of smokes out of my hand and chucked them to the middle of a retaining pond near our New Mexico State dorm. I had given Keith my permission to do that or something like it “if you ever catch me with a pack of cigarettes again,” which was about seven hours earlier that same day.
July 1st, 2009 by Kurt Niland
The U.S. Food and Drug Administration announced today that it will require drug manufacturers to put boxed warnings on the product labeling for Chantix (varenicline) and Zyban (bupropion hydrochloride, otherwise called Wellbutrin when prescribed as an antidepressant). Both Chantix and Zyban, commonly prescribed to patients as smoking cessation aids, have been linked to serious behavioral changes and other symptoms. Agitation, hostility, depression, and suicidal thoughts and actions are possible side effects that users should be keenly aware of, the FDA warns.
June 19th, 2009 by Kurt Niland
“It’s my mind-set this time,” Eric Wolbert told the St. Louis Post-Dispatch. “This time I’m going into it celebrating that I’m quitting rather than worrying about not being able to and how hard it was.”
June 9th, 2009 by Kurt Niland
Last week, the Food and Drug Administration released a list of about 20 pharmaceutical drugs that the agency’s researchers are closely monitoring for potential safety concerns. Not surprisingly, Chantix (Varenicline) claimed a spot on the list. According to the FDA, the drug is being watched to determine whether it causes or contributes to angiodema (rapid and potentially life-threatening swelling of skin and tissue), other serious skin reactions, visual impairment, and accidental injury.
![[ Beasley Allen Law Firm Logo ]](http://www.chantix-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}